Brakke examines the state of pet cancer
How often the disease strikes, the clinical options and costs are broken down in a new report.
Brakke Consulting has taken a comprehensive look at pets and oncology in the Dallas firm’s new report, “Cancer in Dogs and Cats.”
According to Brakke, the study examines:
- The incidence of cancer in pets.
- How cancer is diagnosed and treated in veterinary medicine.
- Estimated treatment costs.
- FDA-approved cancer treatments that are on the market.
- New and developing veterinary cancer products.
- Estimated sales of veterinary-approved cancer therapies.
- The number of pets treated with chemotherapy or immunotherapy.
“Oncology is one of the highest interest areas in veterinary medicine today,” said senior consultant Lynn Fondon, DVM. “In the past decade, the U.S. has gone from zero cancer therapies approved for veterinary use to a more than a half-dozen, with dozens more in development.”
Caring for cancer-stricken pets can be a business builder for practitioners.
“We found that despite costs that can reach thousands of dollars, many dog and cat owners are willing to pursue treatment when their pets are diagnosed with cancer,” Dr. Fondon said.
More information about the report, the fourth edition in a series that began in 2002, is available at www.brakkeconsulting.com.